Works in European Journal of Nuclear Medicine & Molecular Imaging, 2025, Vol 52, Issue 10

Results: 41
    1

    Harmonizing Aβ deposition threshold for <sup>18</sup>F-florbetaben PET imaging: Addressing discrepancies and calibration between PET/CT and PET/MRI.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3591, doi. 10.1007/s00259-025-07279-y
    By:
    • Lin, Huamei;
    • Jiang, Quanling;
    • Yang, Yunhao;
    • Huang, Qi;
    • Zhang, Ying;
    • Zhang, Zhengwei;
    • Zhu, Yuhua;
    • Lu, Jiaying;
    • Wang, Jing;
    • Wang, Min;
    • Men, Jianwei;
    • Yang, Yufeng;
    • Zhang, Huiwei;
    • Guan, Yihui;
    • Ge, Jingjie;
    • Lu, Jie;
    • Jiang, Jiehui;
    • Zuo, Chuantao
    Publication type:
    Article
    2
    3
    4
    5

    Quantification of baseline amyloid PET in individuals with subjective cognitive decline can identify risk of amyloid accumulation and cognitive worsening: the FACEHBI study.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3578, doi. 10.1007/s00259-025-07270-7
    By:
    • Kolinger, Guilherme Domingues;
    • Sotolongo-Grau, Oscar;
    • Roé-Vellvé, Núria;
    • Tartari, Juan Pablo;
    • Sanabria, Ángela;
    • Pérez-Martínez, Esther;
    • Koglin, Norman;
    • Stephens, Andrew W.;
    • Alegret, Montserrat;
    • Tárraga, Lluís;
    • Gurruchaga, Miren Jone;
    • Ruiz, Agustín;
    • Boada, Mercè;
    • Bullich, Santiago;
    • Marquié, Marta;
    • on behalf of the FACEHBI study group;
    • Aguilera, N.;
    • Alarcón-Martín, E.;
    • Alegret, M.;
    • Alllué, J. A.
    Publication type:
    Article
    6
    7
    8
    9
    10

    Total or partial adrenalectomy for aldosterone-producing adenoma: can <sup>68</sup>Ga-Pentixafor PET/CT predict surgical outcomes?

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3632, doi. 10.1007/s00259-025-07244-9
    By:
    • Zheng, Wen-Cai;
    • Chen, Shao-Ming;
    • Qiu, Qian-Renshun;
    • Li, Xiao-Dong;
    • Lin, Fei;
    • Shen, Xi-Mei;
    • Fang, Zhou-Fei;
    • Xue, Yu-Ting;
    • Lin, Bin;
    • Sun, Xiong-Lin;
    • Zheng, Qing-Shui;
    • Wei, Yong;
    • Lin, Yong-Ping;
    • Xiong, Hao;
    • Xue, Xue-Yi;
    • Ke, Zhi-Bin;
    • Xu, Ning
    Publication type:
    Article
    11
    12

    External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3744, doi. 10.1007/s00259-025-07241-y
    By:
    • Van Bergen, Tessa D.;
    • Braat, Arthur J. A. T.;
    • Hermsen, Rick;
    • Heetman, Joris G.;
    • Wever, Lieke;
    • Lavalaye, Jules;
    • Vinken, Maarten;
    • Bahler, Clinton D.;
    • Tann, Mark;
    • Kesch, Claudia;
    • Telli, Tugce;
    • Chiu, Peter Ka-Fung;
    • Wu, Kwan Kit;
    • Zattoni, Fabio;
    • Evangelista, Laura;
    • Ceci, Francesco;
    • Miszczyk, Marcin;
    • Rajwa, Pawel;
    • Barletta, Francesco;
    • Gandaglia, Giorgio
    Publication type:
    Article
    13

    Prospective clinical study of sentinel node detection in bladder cancer using a hybrid tracer – Towards replacement of pelvic lymph node dissection in cases with sentinel node visualization on SPECT/CT?

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3653, doi. 10.1007/s00259-025-07240-z
    By:
    • van Gennep, E. J.;
    • Pisano, G.;
    • KleinJan, G. H.;
    • Rietbergen, D. D. D.;
    • Hendricksen, K.;
    • Mertens, L. S.;
    • vd Kamp, M. W.;
    • Wit, E. M. K.;
    • van Montfoort, M. L.;
    • Donswijk, M.;
    • van Rhijn, B. W. G.;
    • van Leeuwen, F. W. B.;
    • van der Poel, H. G.
    Publication type:
    Article
    14
    15

    Safety and efficacy of re-treatment with [<sup>177</sup>Lu]Lu-DOTA-Octreotate radionuclide therapy in progressive gastro-entero-pancreatic neuroendocrine tumours – a single centre experience.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3672, doi. 10.1007/s00259-025-07235-w
    By:
    • Kashyap, Raghava;
    • Alipour, Ramin;
    • Boehm, Emma;
    • Jewell, Kerry;
    • RaviKumar, Aravind S.;
    • Cardin, Anthony;
    • Saghebi, Javad;
    • Hofman, Michael S.;
    • Fahey, Michael T.;
    • Michael, Michael;
    • Akhurst, Tim;
    • Hicks, Rodney J.;
    • Kong, Grace
    Publication type:
    Article
    16

    The diagnostic performance of [<sup>18</sup>F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [<sup>11</sup>C]PiB and [<sup>18</sup>F]Florbetapir.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3557, doi. 10.1007/s00259-025-07233-y
    By:
    • Wu, Meiqi;
    • Li, Yuying;
    • Liang, Menglin;
    • Mao, Chenhui;
    • Dong, Liling;
    • Ge, Qi;
    • Wu, Runze;
    • Ren, Chao;
    • Zhang, Haiqiong;
    • Huang, Zhenghai;
    • Xing, Haiqun;
    • Yang, Xueqian;
    • Wang, Yuan;
    • Feng, Feng;
    • Cui, Mengchao;
    • Gao, Jing;
    • Huo, Li
    Publication type:
    Article
    17
    18
    19
    20

    Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3820, doi. 10.1007/s00259-025-07229-8
    By:
    • Lam, Marnix;
    • Salem, Riad;
    • Toskich, Beau;
    • Kappadath, S. Cheenu;
    • Chiesa, Carlo;
    • Fowers, Kirk;
    • Haste, Paul;
    • Herman, Joseph M.;
    • Kim, Edward;
    • Leung, Thomas;
    • Padia, Siddharth A.;
    • Sangro, Bruno;
    • Sze, Daniel Y.;
    • Garin, Etienne
    Publication type:
    Article
    21
    22
    23

    Chinese management guidelines for radioactive iodine-refractory differentiated thyroid cancer (2025 edition).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3859, doi. 10.1007/s00259-025-07222-1
    By:
    • Lin, Yan-Song;
    • Wang, Ren-Fei;
    • Huang, Rui;
    • Wen, Qiang;
    • Cao, Wei;
    • Chen, Li-Bo;
    • Guo, Ye;
    • Hou, Xiao-Rong;
    • Li, Li;
    • Li, Xiao-Yi;
    • Lin, Cheng-He;
    • Liu, Zhi-Yan;
    • Wang, Hao;
    • Wang, Xu-Fu;
    • Wang, Zhuo-Ying;
    • Wu, Xiao-Hong;
    • Xu, Shu-Hang;
    • Yang, Ai-Min;
    • Zhang, Bo;
    • Zhang, Yue-Lun
    Publication type:
    Article
    24
    25

    Prognostic value of [<sup>18</sup>F]fluorodeoxyglucose-PET/MRI(CT) novel interpretation criteria (IMPeTUs) in multiple myeloma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3781, doi. 10.1007/s00259-025-07219-w
    By:
    • Zhang, Miao;
    • Cai, Tangjia;
    • Jin, Shiwei;
    • Huang, Xinyun;
    • Gao, Yuting;
    • Chen, Xiaoyue;
    • Ouyang, Wanyan;
    • Tao, Yi;
    • Liu, Yuanfang;
    • Wang, Yan;
    • Meng, Hongping;
    • Li, Jian;
    • Lin, Xiaozhu;
    • Shi, Kuangyu;
    • Wang, Jin;
    • Ding, Xiaoyi;
    • Mi, Jian-Qing;
    • Li, Biao
    Publication type:
    Article
    26

    [<sup>177</sup>Lu]Lu-EDTMP —a bone pain palliating agent: pharmacokinetics, biodistribution, safety profile and clinical evaluation in osseous metastatic patients.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3757, doi. 10.1007/s00259-025-07218-x
    By:
    • Saeed, Shabana;
    • Paez, Diana;
    • Estrada Lobato, Enrique;
    • Delgado Bolton, Roberto C.;
    • Jameel, Ghazal;
    • Qureshi, Farida;
    • Pellet, Olivier;
    • Brink, Anita;
    • Soto, Adrian;
    • Grigoryan, Anna;
    • Knoll, Peter;
    • Giammarile, Francesco
    Publication type:
    Article
    27
    28
    29
    30
    31

    Prospective comparison of <sup>18</sup>F-PSMA-1007 PET/CT and MRI with histopathology as the reference standard for intraprostatic tumour detection and T-staging of high-risk prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3709, doi. 10.1007/s00259-025-07208-z
    By:
    • Kivikallio, Aino;
    • Malaspina, Simona;
    • Saarinen, Irena;
    • Seppänen, Marko;
    • Anttinen, Mikael;
    • Jambor, Ivan;
    • Verho, Janne;
    • Kemppainen, Jukka;
    • Aronen, Hannu J.;
    • Boström, Peter J.;
    • Ettala, Otto;
    • Taimen, Pekka
    Publication type:
    Article
    32
    33
    34
    35

    Exploring the origins of frequent tau-PET signal in vermal and adjacent regions.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3519, doi. 10.1007/s00259-025-07199-x
    By:
    • Kling, Agnes;
    • Kusche-Palenga, Julia;
    • Palleis, Carla;
    • Jäck, Alexander;
    • Bernhardt, Alexander M.;
    • Frontzkowski, Lukas;
    • Roemer, Sebastian N.;
    • Slemann, Luna;
    • Zaganjori, Mirlind;
    • Scheifele, Maximilian;
    • Paeger, Lars;
    • Bischof, Gérard N.;
    • van Eimeren, Thilo;
    • Drzezga, Alexander;
    • Sabri, Osama;
    • Rullmann, Michael;
    • Barthel, Henryk;
    • Levin, Johannes;
    • Herms, Jochen;
    • Franzmeier, Nicolai
    Publication type:
    Article
    36
    37

    Correction to: Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine‑induced hypo‑vascularization.

    Published in:
    2025
    By:
    • Heid, Irina;
    • Trajkovic-Arsic, Marija;
    • Lohöfer, Fabian;
    • Kaissis, Georgios;
    • Harder, Felix N.;
    • Mayer, Moritz;
    • Topping, Geoffrey J.;
    • Jungmann, Friderike;
    • Crone, Barbara;
    • Wildgruber, Moritz;
    • Karst, Uwe;
    • Liotta, Lucia;
    • Algül, Hana;
    • Yen, Hsi-Yu;
    • Steiger, Katja;
    • Weichert, Wilko;
    • Siveke, Jens T.;
    • Makowski, Marcus R.;
    • Braren, Rickmer F.
    Publication type:
    Correction Notice
    38
    39
    40
    41

    Early changes of PSMA PET expression after initiation of androgen receptor signaling inhibitors in CRPC: an international multicenter retrospective study.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 10, p. 3700, doi. 10.1007/s00259-025-07178-2
    By:
    • Unterrainer, Lena M.;
    • Farolfi, Andrea;
    • Grogan, Tristan;
    • Hotta, Masatoshi;
    • Djaileb, Loïc;
    • Gafita, Andrei;
    • Sonni, Ida;
    • Rettig, Matthew B.;
    • Rosar, Florian;
    • Ezziddin, Samer;
    • Denis, Chloé S.;
    • de Kouchkovsky, Ivan;
    • Aggarwal, Rahul;
    • Emmett, Louise;
    • Hope, Thomas A.;
    • Czernin, Johannes;
    • Calais, Jeremie
    Publication type:
    Article